Efficacy of first-line ART regimens based on tenofovir in HIV-infected patients with pre-existing A62V mutation in reverse transcriptase.
Ekaterina OzhmegovaA I KuznetsovaAleksey LebedevAnastasiia AntonovaK V KimI M MunchakA S TumanovE V KazennovaPublished in: Voprosy virusologii (2024)
This study has some limitations, and the exact role of A62V in the efficacy of the first-line ART based on tenofovir deserves further investigation.